Dissemination (Meeting Coverage)

The following is a summary of “(NEURO)INFLAMMATORY BIOMARKERS MEDIATE THE ASSOCIATION...

The following is a summary of “IMPACT OF HIV RESERVOIR IN THE LOSS OF NATURAL ELITE CONTROL...

The following is a summary of “ONE-YEAR MORTALITY OF PEOPLE WITH HIV AFTER INTENSIVE CARE...

The following is a summary of “PAGE-B SCORE TO ESTIMATE THE HEPATOCELLULAR CARCINOMA RISK IN...

In HCC with macroscopic vascular invasion, hepatic resection was significantly linked with better...

In patients with rectal cancer, neoadjuvant radiotherapy (RT) followed by atezolizumab and...

Adding bevacizumab to atezolizumab plus cisplatin and gemcitabine did not significantly improve...

The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI)...

The triplet regimen of nab-paclitaxel plus gemcitabine plus cisplatin (GCN) did not improve the...

The postoperative adjuvant combination therapy of sorafenib plus transarterial chemoembolization...

Patients with pre-treated, advanced biliary tract cancer (BTC) may benefit from treatment with...

The phase 3 NAPOLI-3 trial showed that liposomal irinotecan plus 5-fluorouracil/leucovorin and...

Zolbetuximab added to mFOLFOX6 improved the progression-free survival (PFS) and overall survival...

Single fraction radiation therapy (RT) outperformed best supportive care in reducing hepatic pain...

Therapy with atezolizumab (atezo) plus bevacizumab (bev) in systemic treatment (tx)-naive patients...

Atezolizumab plus bevacizumab (A+B) is the new standard of care for first-line treatment of...

In the treatment of hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) based...

Hepatocellular carcinoma (HCC) is the most rapidly expanding cause of cancer-related mortality in...

Patients with chronic lymphocytic leukemia (CLL) infected with COVID-19 during the most recent...

Measurable/minimal residual disease (MRD) assessment by qPCR was strongly associated with clinical...